Literature DB >> 23726134

The role of religion in decision-making on antenatal screening of congenital anomalies: a qualitative study amongst Muslim Turkish origin immigrants.

Janneke T Gitsels-van der Wal1, Judith Manniën2, Mohammed M Ghaly3, Pieternel S Verhoeven4, Eileen K Hutton5, Hans S Reinders6.   

Abstract

OBJECTIVE: to explore what role religious beliefs of pregnant Muslim women play in their decision-making on antenatal screening, particularly regarding congenital abnormalities and termination, and whether their interpretations of the religious doctrines correspond to the main sources of Islam.
DESIGN: qualitative pilot study using in-depth interviews with pregnant Muslim women.
SETTING: one midwifery practice in a medium-sized city near Amsterdam participated in the study. PARTICIPANTS: 10 pregnant Muslim women of Turkish origin who live in a high density immigrant area and who attended primary midwives for antenatal care were included in the study. DATA COLLECTION AND DATA ANALYSIS: to explore the role of religion in decision-making on antenatal screening tests, a topic list was constructed, including four subjects: being a (practising) Muslim, the view on unborn life, the view on disabled life and the view on termination. To analyse the interviews, open and axial coding based on the Grounded Theory was used and descriptive and analytical themes were identified and interpreted.
FINDINGS: all 10 interviewees stated that their faith played a role in their decision-making on antenatal screening, specific to the combined test. They did not consider congenital anomalies as a problem and did not consider termination to be an option in case of a disabled fetus. However, the Islamic jurisprudence considers that termination is allowed if the fetus has serious abnormalities, but only before 19 weeks plus one day of gestation. KEY
CONCLUSIONS: religious convictions play a role regarding antenatal screening in pregnant Muslim women of Turkish origin. The interviewees did not consider a termination in case of an affected child. Women were unaware that within Islamic tradition there is the possibility of termination if a fetus has serious anomalies. Incomplete knowledge of religious doctrines may be influencing both decisions of antenatal screening and diagnostic tests uptake and of terminating a pregnancy for fetuses with serious anomalies. IMPLICATIONS FOR PRACTISE: counsellors should be aware of the role of religious beliefs in the decision-making process on antenatal screening tests.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antenatal diagnosis; Combined test; Congenital anomalies; Islam

Mesh:

Year:  2013        PMID: 23726134     DOI: 10.1016/j.midw.2013.04.001

Source DB:  PubMed          Journal:  Midwifery        ISSN: 0266-6138            Impact factor:   2.372


  12 in total

1.  Responsible implementation of expanded carrier screening.

Authors:  Lidewij Henneman; Pascal Borry; Davit Chokoshvili; Martina C Cornel; Carla G van El; Francesca Forzano; Alison Hall; Heidi C Howard; Sandra Janssens; Hülya Kayserili; Phillis Lakeman; Anneke Lucassen; Sylvia A Metcalfe; Lovro Vidmar; Guido de Wert; Wybo J Dondorp; Borut Peterlin
Journal:  Eur J Hum Genet       Date:  2016-03-16       Impact factor: 4.246

2.  Decision-making on terminating pregnancy for Muslim Arab women pregnant with fetuses with congenital anomalies: maternal affect and doctor-patient communication.

Authors:  Anat Gesser-Edelsburg; Nour Abed Elhadi Shahbari
Journal:  Reprod Health       Date:  2017-04-04       Impact factor: 3.223

3.  Healthcare needs of the Muslim patient community in the undergraduate medical curriculum - Are we there?

Authors:  Hameedul Haq; Rehan Ahmed Khan; Raheela Yasmin
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

4.  Controversies and considerations regarding the termination of pregnancy for foetal anomalies in Islam.

Authors:  Abdulrahman Al-Matary; Jaffar Ali
Journal:  BMC Med Ethics       Date:  2014-02-05       Impact factor: 2.652

5.  The attitudes and intention to participate in hemoglobinopathy carrier screening in The Netherlands among individuals from Turkish, Moroccan, and Surinamese descent.

Authors:  Sylvia M van der Pal; Nicole M C van Kesteren; Jacobus P van Wouwe; Paula van Dommelen; Symone B Detmar
Journal:  J Environ Public Health       Date:  2013-11-17

6.  Prenatal screening for congenital anomalies: exploring midwives' perceptions of counseling clients with religious backgrounds.

Authors:  Janneke T Gitsels-van der Wal; Judith Manniën; Lisanne A Gitsels; Hans S Reinders; Pieternel S Verhoeven; Mohammed M Ghaly; Trudy Klomp; Eileen K Hutton
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-19       Impact factor: 3.007

7.  Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study.

Authors:  Janneke T Gitsels-van der Wal; Pieternel S Verhoeven; Judith Manniën; Linda Martin; Hans S Reinders; Evelien Spelten; Eileen K Hutton
Journal:  BMC Pregnancy Childbirth       Date:  2014-08-09       Impact factor: 3.007

Review 8.  Factors Affecting Improved Prenatal Screening: A Narrative Review.

Authors:  Zohreh Shahhosseini; Hoda Arabi; Azam Salehi; Zeinab Hamzehgardeshi
Journal:  Glob J Health Sci       Date:  2015-09-28

9.  Experiences and preferences of care among Swedish immigrants following a prenatal diagnosis of congenital heart defect in the fetus: a qualitative interview study.

Authors:  Tommy Carlsson; Ulla Melander Marttala; Elisabet Mattsson; Anders Ringnér
Journal:  BMC Pregnancy Childbirth       Date:  2016-06-02       Impact factor: 3.007

10.  Ethnicity and Language Proficiency Differences in the Provision of and Intention to Use Prenatal Screening for Down's Syndrome and Congenital Anomalies. A Prospective, Non-selected, Register-Based Study in the Netherlands.

Authors:  Ingrid A Peters; Kirsten M Heetkamp; Nicolette T C Ursem; Eric A P Steegers; Semiha Denktaş; Maarten F C M Knapen
Journal:  Matern Child Health J       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.